Intrinsic Value of S&P & Nasdaq Contact Us

Aeolus Pharmaceuticals, Inc. AOLS OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
9/100
0/3 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aeolus Pharmaceuticals, Inc. (AOLS) has 8 known insider and institutional holders on record. The largest holder is XMARK ASSET MANAGEMENT LLC with 9,367,482 shares. Other notable holders include Efficacy Capital, Ltd. and McManus John L.

AOLS Insider Ownership

Top Holder
XMARK ASSET MANAGEMENT LLC
9,367,482 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Xmark Asset Management Llc 10 Percent Owner 9,367,482 2005-09-09
100%
2 Efficacy Capital, Ltd. 10 Percent Owner 8,148,812 2011-03-17
87%
3 Mcmanus John L President and CEO 250,000 2016-12-30
3%
4 Skibsted Russell Chief Financial Officer 150,000 2013-03-11
2%
5 Kumar Amit Director 100,000 2016-02-03
1%
6 Suzdak Peter David Director 75,000 2013-05-10
1%
7 Lewis Michael E Director 75,000 2013-05-10
1%
8 Cavalier David Director 75,000 2013-05-10
1%

No ownership data available for AOLS.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message